Price range: $195.00 through $381.00
Catalog Number: 11294-05041
Purified antibody validated for specificity and sensitivity.
| Format | IgG-FITC Conjugate |
|---|---|
| Entrez Gene | 718 |
| Associated Disease | Autoimmune Disease, Lupus (SLE) |
| Species | Human |
| UniProt | P01024 |
| Size | Full Size, Trial Size |
| Purity | Affinity Purified |
| Presentation | 0.02% Sodium Azide, 20 mg/ml BSA, and 4% Trehalose, Lyophilized from PBS pH 7.4 |
| Host | Rabbit |
| Storage | 2-8°C, Do Not Freeze |
| Application | FACS, ICC, IF, IHC |
| Immunogen | Human Complement C3d purified from human plasma |
| Label | FITC conjugated |
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria
Phase 2 Study of Danicopan in Paroxysmal Nocturnal Hemoglobinuria Patients with an Inadequate Response to Eculizumab
* Risitano AM et al. (2020) Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria. Haematologica. 2020 Oct 29. doi: 10.3324/haematol.2020.261826
* Kulasekararaj AG et al. (2021) Phase 2 Study of Danicopan in Paroxysmal Nocturnal Hemoglobinuria Patients with an Inadequate Response to Eculizumab. Blood. 29 July 2021; blood.2021011388.
Loading data...
